SCHEMBL731008

SCHEMBL731008

C1CCN(C2CCC[N]2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL236881 0.97 CYP2D6 (0.30)
SCHEMBL10891279 0.93 CYP2D6 (0.32)
SCHEMBL4712511 0.93 CYP2D6 (0.32)
SCHEMBL286072 0.93 CYP2D6 (0.32)
SCHEMBL6050828 0.93 CYP2D6 (0.32)
SCHEMBL2229452 0.93 CYP2D6 (0.32)
SCHEMBL2569149 0.93 CYP2D6 (0.32)
SCHEMBL3658217 0.93 CYP2D6 (0.32)
SCHEMBL8640554 0.93 CYP2D6 (0.32)
SCHEMBL8640560 0.93 CYP2D6 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024012570-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 西藏海思科制药有限公司 2024-01-18 WO claimed
WO-2023232133-A1 COMPOUND FOR INHIBITING OR DEGRADING BCL6 AND USE THEREOF IN PHARMACEUTICS 西藏海思科制药有限公司 2023-12-07 WO claimed
WO-2023208165-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2023-11-02 WO claimed
US-20160045490-A1 USE OF CHEMOTHERAPEUTIC AGENTS BAYER INNOVATION GMBH (DE) 2016-02-18 US claimed
US-20140287028-A1 Use of Chemotherapeutic Agents BAYER INNOVATION GMBH (DE) 2014-09-25 US claimed
US-20140256714-A1 MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI JANSSEN PHARMACEUTICA NV (BE) 2014-09-11 US claimed
EP-2203437-B1 CHIRAL CIS-IMIDAZOLINES HOFFMANN LA ROCHE (CH) 2012-11-07 EP claimed
US-8173638-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-08 US claimed
EP-2283008-B1 PYRROLE DERIVATIVES, PREPARATION OF SAME AND THERAPEUTIC APPLICATION THEREOF SANOFI SA (FR) 2011-11-02 EP claimed
EP-1408034-B2 Use of Quinolone and Quinolizinone derivatives as chemotherapeutic agents BAYER INNOVATION GMBH (DE) 2011-05-25 EP claimed
EP-0295769-A2 1,4 Dihydropyridine derivatives, process for their preparation and their uses in pharmaceutical compositions Pfizer Limited (GB) 1988-12-21 EP claimed
EP-0107261-B1 (2-((NITROPYRIDINYL)AMINO)PHENYL)ARYLMETHANONES AND SALTS, THEIR USE IN MEDICINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONES AND PYRIDO(1,4)BENZODIAZEPINES A.H. ROBINS COMPANY, INCORPORATED (US) 1988-09-21 EP claimed
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP claimed
EP-0206114-A2 Novel substituted phthalides and furopyridinones, preparation thereof and use thereof as color formers HILTON-DAVIS CHEMICAL CO. (US) 1986-12-30 EP claimed
EP-0101926-B1 AZOLYL-KETO-ENAMINES BAYER AG (DE) 1986-09-03 EP claimed
EP-0049618-B1 IMPROVEMENTS IN OR RELATING TO 2,4-DISUBSTITUTED THIAZOLE DERIVATIVES ELI LILLY AND COMPANY (US) 1985-08-14 EP claimed
EP-0082244-A1 Novel light stabilizers for polymers AMERICAN CYANAMID COMPANY (US) 1983-06-29 EP claimed
EP-0043642-A1 Phthalimidoguanidines, a method of manufacturing same and the use thereof as plant growth regulators Gulf Oil Corporation (US) 1982-01-13 EP claimed
EP-0005318-B1 N-HETEROCYCLYL-4-PIPERIDINAMINES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, INTERMEDIATES THEREFOR, AND METHOD FOR THE PREPARATION OF THE INTERMEDIATES JANSSEN PHARMACEUTICA N.V. (BE) 1982-01-06 EP claimed
US-3933793-A BACTERICIDES, VIRICIDES RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1976-01-20 US claimed